Franklin BSP Realty Trust, Inc. (FBRT) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Franklin BSP Realty Trust, Inc. is a Maryland corporation taxed as a Real Estate Investment Trust (REIT) that originates, acquires, and manages a diversified portfolio of commercial real estate debt investments. The company is externally managed by Benefit Street Partners L.L.C. (the "Advisor"), a subsidiary of Franklin Resources, Inc. The portfolio primarily consists of commercial mortgage loans, real estate securities (CMBS), and real estate owned (REO) assets acquired through foreclosure or purchase.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Total Income | $49.7 million | $62.4 million | $154.5 million | $209.2 million |
| Net Interest Income | $44.3 million | $59.1 million | $140.3 million | $196.1 million |
| Net Income (GAAP) | $30.2 million | $31.0 million | $62.2 million | $114.5 million |
| Net Income Applicable to Common Stock | $24.9 million | $25.0 million | $45.1 million | $95.0 million |
| Diluted EPS | $0.30 | $0.30 | $0.53 | $1.14 |
| Total Assets | $6.33 billion | $5.96 billion (Dec 31, 2023) | - | - |
| Total Liabilities | $4.72 billion | $4.28 billion (Dec 31, 2023) | - | - |
| Cash & Cash Equivalents | $346.2 million | $337.6 million (Dec 31, 2023) | - | - |
| Net Debt-to-Equity Ratio | 2.7x | 2.3x (Dec 31, 2023) | - | - |
Material Changes vs. Prior Period
- Net Interest Income Decline: Net interest income decreased by $14.8 million (25%) in Q3 2024 compared to Q3 2023. This was driven by an increase in non-performing loans (averaging $189.8 million in principal) and a compression in net interest spread (1.7% in Q3 2024 vs. 3.1% in Q3 2023).
- Interest Expense Increase: Interest expense rose by $11.9 million to $89.9 million, primarily due to a $444.6 million increase in the average carrying balance of Collateralized Loan Obligations (CLOs) and higher deferred fee amortization.
- Credit Loss Provision: The company recorded a benefit for credit losses of $0.3 million in Q3 2024, a significant improvement from a provision of $2.4 million in Q3 2023. However, for the nine months ended September 30, 2024, the provision was $34.8 million compared to $28.4 million in the prior year period, driven by specific provisions on non-performing office loans and multifamily foreclosures.
- Real Estate Owned (REO): Revenue from REO increased to $5.4 million in Q3 2024 from $3.3 million in Q3 2023, due to rental income from newly acquired multifamily properties. However, the company recorded a loss of $2.2 million on other real estate investments, largely due to write-downs on the Walgreens Portfolio.
- Portfolio Composition: The commercial mortgage loan portfolio grew to 157 loans with a carrying value of $5.08 billion. Multifamily loans represent 73.8% of the portfolio by par value.
Guidance, Outlook, and Risks
- Liquidity: The company reported $1.13 billion in total near-term liquidity sources as of September 30, 2024, including $346 million in unrestricted cash and $138 million in CLO reinvestment capital. Management believes this is sufficient to meet obligations for the next 12 months.
- Dividends: The Board declared a quarterly common stock dividend of $0.355 per share (annualized $1.42). Preferred dividends were also declared for Series H ($106.216/share) and Series E ($0.46875/share).
- Share Repurchases: The company has a $65 million share repurchase program with $31.1 million remaining as of September 30, 2024. No shares were repurchased in Q3 2024. The program term was extended to December 31, 2025.
- Risks:
- Credit Risk: Three loans (one multifamily, two office) are designated as non-performing with a combined amortized cost of $67.9 million. Specific allowances for credit losses on these loans total $28.7 million.
- Interest Rate Risk: The portfolio is sensitive to interest rate fluctuations. A 50 basis point increase in rates would increase net interest income by approximately 1.7%, while a 50 basis point decrease would reduce it by 1.58%.
- Real Estate Risk: Ongoing write-downs on the Walgreens Portfolio and other REO assets pose a risk to earnings. The company is actively marketing these properties for sale.
Investor Verification Checklist
- Verify the status and recovery potential of the three non-performing loans (two office, one multifamily) carrying a $28.7 million specific allowance.
- Monitor the valuation and sale progress of the Walgreens Portfolio and other REO assets held for sale ($284.4 million carrying value).
- Assess the impact of rising interest rates on the company's floating-rate debt obligations, particularly the $4.1 billion in CLO liabilities.
- Review the company's ability to maintain its REIT qualification given the mix of taxable REIT subsidiary (TRS) income and distribution requirements.
- Track the utilization of the $138 million CLO reinvestment capital and the $645 million in available financing lines for future origination.